MedTrace Logo

Severe Aortic Valve Stenosis and Concomitant Coronary Artery Disease in Patients Undergoing TAVI

NCT04385459 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 346

Last updated 2021-09-09

No results posted yet for this study

Summary

Patients undergoing surgical aortic valve replacement (sAVR) with concomitant coronary artery disease (CAD) are known to have higher mortality rates compared to patients without CAD. This same phenomenom has not been clearly mapped in patients with CAD that goes through a transcatheter aortic valve implantation procedure.

Conditions

Interventions

OTHER

Coronary artery disease

Exposure

Sponsors & Collaborators

  • Örebro County Council

    lead OTHER_GOV

Principal Investigators

  • Ninos Samano, MD,PhD · Department of Cardiothoracic and Vascular Surgery, Örebro University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-13
Primary Completion
2020-12-24
Completion
2020-12-24

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04385459 on ClinicalTrials.gov